Skip to main content
Clinical Trials/JPRN-UMIN000025996
JPRN-UMIN000025996
Completed
未知

A study for evaluating the effect of the intake of the test products on postprandial hyperglycemia for healthy male - A study for evaluating the effect of the intake of the test products on postprandial hyperglycemia for healthy male

TTC Co.,Ltd.0 sites12 target enrollmentFebruary 3, 2017
ConditionsHealthy male

Overview

Phase
未知
Intervention
Not specified
Conditions
Healthy male
Sponsor
TTC Co.,Ltd.
Enrollment
12
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 3, 2017
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
TTC Co.,Ltd.

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\)Subjects routinely taking medicine or health food which may influence glucose metabolism. (2\)Subjects who have abnormal glucose tolerance within the one month prior on preliminary examination. (3\)Subjects who have body mass index (BMI) less than 18\.5 kg per square meter or more than 25\.0 kg per square meter. (4\)Subjects who have abnormal glucose tolerance on preliminary examination (5\)Subjects who work at night or have irregular life more than one time in the study. (6\)Subjects who are planning to go overseas. (7\)Subjects with allergies to the test food in the study. (8\)Subjects who drink alcohol a lot. (9\)Subjects who smoke a lot. (10\)Subjects who has serious illness such as diabetes, liver disease, kidney disease, heart disease, digestive system disease. (11\)Subjects who have a disease under medication or having a history of study such as obesity, dyslipidemia, hypertension or who has a serious disease. (12\)Subject who are judged as unsuitable for the study from clinical measurements for preliminary tests and measurements. (13\)Subjects who have participated in other clinical study within the last one month or have planned to participate other clinical studies. (14\)Subjects who are judged as unsuitable for the study from questionnaire. (15\)Subjects who are judged as ineligible by clinical investigator.

Outcomes

Primary Outcomes

Not specified

Similar Trials